You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: RE31463


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE31463
Title: Radiopharmaceutical chelates and method of external imaging
Abstract:A chelate of technetium-99m, cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and substituted iminodiacetic acid or an 8-hydroxyquinoline useful as a radiopharmaceutical external imaging agent. The invention also includes preparative methods therefor.
Inventor(s): Loberg; Michael D. (New Brunswick, NJ), Callery; Patrick S. (Luthersville, MD), Cooper; Malcolm (Chicago, IL)
Assignee: Research Corporation (New York, NY)
Application Number:06/148,052
Patent Claim Types:
see list of patent claims
Compound; Composition; Use; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using the Example of U.S. Patent RE31463

Understanding the Basics of U.S. Patents

Before diving into the specifics of U.S. Patent RE31463, it's crucial to understand the fundamental concepts of U.S. patents. Patents are granted by the United States Patent and Trademark Office (USPTO) and provide the inventor with the exclusive right to make, use, or sell the invention for a specified period, typically 20 years from the filing date of the patent application[4].

The Importance of Patent Claims

Patent claims are the most critical part of any patent application. They define the scope of the invention and determine what is protected by the patent. Claims can be broad or narrow, and their interpretation is key in determining the validity and enforceability of the patent[3].

U.S. Patent RE31463: An Overview

To analyze the scope and claims of U.S. Patent RE31463, one must first obtain the patent document from the USPTO database or other patent search platforms. Here is a hypothetical analysis based on common practices in patent analysis.

Patent Title and Abstract

The title and abstract provide a brief overview of the invention. For example, if U.S. Patent RE31463 pertains to a technological innovation in the field of electrical engineering, the title might reflect this, and the abstract would summarize the key aspects of the invention.

Background of the Invention

This section provides context about the existing technology and the problems that the invention aims to solve. It helps in understanding the novelty and non-obviousness of the invention.

Summary of the Invention

This section gives a detailed description of the invention, including its components, how it works, and its advantages over existing technologies.

Analyzing Patent Claims

Independent and Dependent Claims

Patent claims are categorized into independent and dependent claims. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit the independent claims[3].

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is often a critical issue in patent litigation, as the scope of the claims determines what is protected by the patent. The courts use various rules and guidelines to construe the claims, including the plain meaning of the words, the specification, and the prosecution history of the patent[2].

Scope Concepts and Claim Coverage Matrix

To understand the scope of U.S. Patent RE31463, a Claim Coverage Matrix can be useful. This matrix categorizes the patents and claims by scope concepts, which are overarching themes that link similar claims across different patents. This approach helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Tracking Patents by Claims and Scope Concepts

By categorizing the claims under specific scope concepts, you can filter, search, and analyze large numbers of patent claims efficiently. This method is particularly useful for companies with extensive patent portfolios, as it helps in determining the value of each patent claim and identifying areas where claim coverage is lacking.

Patent Landscape Analysis

Technology Area Classification

Patents can be classified into various technology areas, such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, and Mechanical. This classification helps in understanding the broader patent landscape and how U.S. Patent RE31463 fits into it[1].

Continuation Procedures and Family Allowance Rates

Understanding continuation procedures is crucial for analyzing the patent landscape. Continuation applications can lead to multiple patents from a single progenitor application, complicating the calculation of allowance rates. For example, 31% of progenitor applications utilize at least one continuation procedure, and 15.8% result in at least one serialized continuation[1].

Case Law and Litigation Implications

Obviousness-Type Double Patenting

In the context of U.S. Patent RE31463, if there are multiple related patents, the issue of obviousness-type double patenting might arise. This doctrine prevents the issuance of multiple patents for the same invention or for inventions that are not patentably distinct from each other. Recent cases, such as Allergan USA, Inc. v. MSN Laboratories Private Ltd., highlight the importance of this doctrine in patent litigation[2].

Written Description Requirement

The written description requirement under 35 U.S.C. § 112 is another critical aspect. The claims must be supported by a sufficient written description in the specification to be valid. Failure to meet this requirement can lead to the invalidation of the patent claims, as seen in the Allergan case[2].

Tools and Software for Patent Analytics

ClaimScape® Software

Tools like ClaimScape® software can be invaluable in analyzing patent claims and scope concepts. These tools generate interactive claim charts that help technical experts and management review patent coverage, identify gaps, and highlight future design opportunities[3].

Key Takeaways

  • Patent Claims: The claims are the heart of any patent application and define the scope of protection.
  • Scope Concepts: Categorizing claims under scope concepts helps in efficient analysis and identification of gaps in patent coverage.
  • Continuation Procedures: Understanding continuation procedures is essential for analyzing the patent landscape and calculating allowance rates.
  • Case Law: Recent cases highlight the importance of doctrines like obviousness-type double patenting and the written description requirement in patent litigation.
  • Patent Analytics Tools: Utilizing tools like ClaimScape® software can enhance the efficiency and accuracy of patent analysis.

FAQs

What is the significance of patent claims in a U.S. patent?

Patent claims define the scope of the invention and determine what is protected by the patent. They are the most critical part of any patent application.

How do continuation procedures affect patent allowance rates?

Continuation procedures can lead to multiple patents from a single progenitor application, complicating the calculation of allowance rates. About 31% of progenitor applications utilize at least one continuation procedure[1].

What is obviousness-type double patenting?

Obviousness-type double patenting prevents the issuance of multiple patents for the same invention or for inventions that are not patentably distinct from each other. This doctrine is crucial in patent litigation to avoid redundant patent protection[2].

Why is the written description requirement important?

The written description requirement under 35 U.S.C. § 112 ensures that the claims are supported by a sufficient written description in the specification. Failure to meet this requirement can lead to the invalidation of the patent claims[2].

How can patent analytics tools help in managing a patent portfolio?

Patent analytics tools, such as ClaimScape® software, help in categorizing claims under scope concepts, identifying gaps in patent coverage, and highlighting future design opportunities. These tools enhance the efficiency and accuracy of patent analysis[3].

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. Retrieved from https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  2. United States Court of Appeals for the Federal Circuit. (2024, August 13). ALLERGAN USA, INC. v. MSN LABORATORIES PRIVATE LTD.. Retrieved from https://cafc.uscourts.gov/opinions-orders/24-1061.OPINION.8-13-2024_2366074.pdf
  3. Schwegman Lundberg & Woessner, P.A. (n.d.). Patent Analytics. Retrieved from https://www.slwip.com/services/patent-analytics/
  4. National Science Foundation. (2020, January 15). Invention: U.S. and Comparative Global Trends. Retrieved from https://ncses.nsf.gov/pubs/nsb20204/invention-u-s-and-comparative-global-trends

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE31463

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent RE31463

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1189776 ⤷  Subscribe
Belgium 840556 ⤷  Subscribe
Canada 1070695 ⤷  Subscribe
Canada 1083038 ⤷  Subscribe
Canada 1096399 ⤷  Subscribe
Germany 2612698 ⤷  Subscribe
France 2322586 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.